Immunohistochemistry analysis also revealed that IRCR201 significantly inhibited the proliferation of tumor cells and angiogenesis of tumor-associated blood vessels, suggesting that IRCR201 suppresses the HGF/c-Met pathway in the tumor microenvironment. Here, MET is linked to neoplasm.